Daily Outlook: Iran’s Nuclear Talks Have Entered a Decisive Stage

The use of overnight reverse repo by the Federal Reserve broke through a record high of $486 billion:

Demand for a tool used by the Fed to control short-term interest rates soared to a record high as huge amounts of cash were looking for a place to go. The Fed’s overnight reverse repo tool-the way counterparties such as money market funds deposit cash with the central bank-absorbed a total of $486.097 billion from 46 participants on Monday. That surpassed the previous record high of $485.3 billion on May 27 and up from $483.3 billion on Friday, according to data released by the New York Fed. Although the Fed’s tool offers an interest rate of 0%, demand has been growing as a flood of cash flooded the dollar financing market. This is partly due to asset purchases by the central bank and a reduction in cash held by the Ministry of Finance, which has led to the inflow of reserves into the financial system.

The Securities and Exchange Commission says it is reviewing market fluctuations in Internet celebrity stocks:

As online celebrity stocks such as AMC Entertainment Holdings continue to soar, the US Securities and Exchange AMC US Equity Exchange Commission said it was reviewing the market for signs of share price manipulation and other misconduct. “in view of the continued volatility of some stocks, SEC staff continue to monitor the market to determine if there are market disruptions, trading manipulation or other misconduct,” SEC said in an emailed statement on Monday. “in addition, if violations of federal securities laws are found, we will take action to protect retail investors.”

Russian authorities encourage trade to turn to euro settlement denying that administrative measures will be used to ban the dollar:

In order to reduce the impact of US sanctions on the Russian economy, the Russian Ministry of Finance said on Monday that it would use economic stimulus to encourage companies, including state giants, to settle trade in euros rather than dollars. However, Russia does not consider imposing any restrictions on the use of dollars. “the Russian Ministry of Finance supports this transition, including the development of appropriate regulatory incentives,” the Ministry of Finance said in a statement on Monday. Of course, incentives will not include any ban, only economic means. “

Emerging market ETF has attracted nearly $30 billion this year, with the largest inflow of investment in China ETF in the most recent week:

ETF has received inflows of more than $1 billion for the third week in a row, bringing inflows of nearly $30 billion so far this year. So far this year, ETF inflows listed in the US, investing extensively in emerging markets or specifically investing in specific emerging markets have totaled $29.3 billion. The ETF received inflows of $1.42 billion in the week ended June 4, compared with $1.74 billion the week before, according to data compiled by Bloomberg. This is the first time such ETF has been bought by investors for 31 consecutive weeks.

The latest research from the US Centers for Disease Control and Prevention shows that the mRNA COVID-19 vaccine can reduce the risk of infection by 91%:

A new study by (CDC) of the US Centers for Disease Control and Prevention has found that the (FDA)-licensed (FDA) COVID-19 vaccine of the US Food and Drug Administration can reduce the risk of infection in people who are fully vaccinated by 91 per cent. The study involved people who were more likely to come into contact with novel coronavirus.

The International Atomic Energy Agency says Iran’s nuclear talks have entered a decisive stage:

International Atomic Energy Agency Director General Rafael Mariano Grossi (Rafael Mariano Grossi) told reporters at a news conference that negotiations between Iran and world powers to resume the 2015 nuclear agreement are entering a decisive stage and that “ongoing negotiations are very serious.” Diplomats are scheduled to hold the next round of talks in Vienna this week, aimed at reviving the nuclear deal and easing sanctions on Iran’s economy and oil sector.

The share price of Bojian soared. The company’s Alzheimer’s drug was approved by FDA:

Bojian’s controversial treatment for Alzheimer’s disease has been approved by US regulators, a landmark decision that will greatly change the treatment of brain function degradation. The accelerated approval of the antibody therapy by the US Food and Drug Administration means that Bojian needs to conduct more research to determine the benefits of the drug in order to keep the drug on the market. FDA announced on Monday that it would allow the drug to go on the market because it reduces levels of amyloid, a sticky, harmful protein that blocks the brains of people with Alzheimer’s disease.

More insight: https://www.jrfx.com/en/education/market-insights.html

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store